Sophia Primary Analysis: A Phase 3 (P3) Study of Margetuximab (M) plus Chemotherapy (C) Versus Trastuzumab (T) plus C in Patients (Pts) with Her2+Metastatic (Met) Breast Cancer (Mbc) After Prior Anti-Her2 Therapies (Tx).

AuthID
P-00R-4AD
19
Author(s)
Im, SA
·
Wright, GLS
·
Escriva de Romani, S
·
DeLaurentiis, M
·
Cortes, J
·
Bahadur, SW
·
Haley, BB
·
Oyola, RH
·
Riseberg, DA
·
Musolino, A
·
Cardoso, F
·
Curigliano, G
·
Kaufman, PA
·
Pegram, MD
·
Edlich, S
·
Hong, S
·
Rock, EP
·
Gradishar, WJ
Document Type
Abstract
Year published
2019
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 37, Issue: 15
Conference
Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 31-JUN 04, 2019, Location: Chicago, IL, Sponsors: Amer Soc Clin Oncol
Indexing
Publication Identifiers
Wos: WOS:000487345803587
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.